• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 180NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 180NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number 0500318E
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/21/2022
Event Type  malfunction  
Event Description
A user facility biomedical technician (bmt) reported that a blood leak occurred immediately after the start of the patient¿s hemodialysis (hd) treatment.The bmt confirmed that the machine, a fresenius 2008t machine, alarmed appropriately with a "minor" blood leak alarm and treatment was immediately discontinued.Blood leak test strips were used and tested negative for the presence of blood.The bmt also stated that fresenius bloodlines were used for treatment and confirmed that the leak was internal and no external blood leak was observed.The bmt stated that there were no defects or damage seen on the dialyzer.Per bmt the patient¿s blood was not returned and stated the estimated blood loss was 250 ml.Immediately following the event, the patient was re-setup with new supplies on the same machine where the patient was able to complete treatment.The bmt confirmed that there was no patient injury, adverse events, or medical intervention required as a result of the reported event.The dialyzer was available to be returned for manufacturer evaluation.
 
Manufacturer Narrative
Plant investigation: the plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
A user facility biomedical technician (bmt) reported that an external dialyzer blood leak occurred immediately after the start of the patient¿s hemodialysis (hd) treatment.The bmt confirmed that the machine, a fresenius 2008t machine, alarmed appropriately with a "minor" blood leak alarm and treatment was immediately discontinued.Blood leak test strips were used and tested negative for the presence of blood.The bmt also stated that fresenius bloodlines were used for treatment and confirmed that a cracked header was observed on the dialyzer.Per bmt the patient¿s blood was not returned and stated the estimated blood loss was 250 ml.Immediately following the event, the patient was re-setup with new supplies on the same machine where the patient was able to complete treatment.The bmt confirmed that there was no patient injury, adverse events, or medical intervention required as a result of the reported event.The dialyzer was available to be returned for manufacturer evaluation.
 
Manufacturer Narrative
Additional information: b5, h6.
 
Manufacturer Narrative
Plant investigation: a sample from the reported lot was returned for evaluation.During the visual examination of the sample, the cavity id end header cap of the dialyzer was observed to have cracks.Cracks were found all the way around the header.No other damage or irregularities were noted on the returned sample.During the lot history review it was noted that there were no other complaints of any kind reported against the lot.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.The investigation into the complaint was able to confirm the reported event.This includes non-conformances, rework, labeling, process controls, and any other occurrence in production that was potentially related to the complaint.The reported lot number passed pyrogen testing, was within sterilization dosage parameters and passed all release criteria.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program, in order to assess and improve our products and processes.Capas 2018-0171 (vision systems) and 1141369 (blood leak reduction) are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.
 
Event Description
A user facility biomedical technician (bmt) reported that an external dialyzer blood leak occurred immediately after the start of the patient¿s hemodialysis (hd) treatment.The bmt confirmed that the machine, a fresenius 2008t machine, alarmed appropriately with a "minor" blood leak alarm and treatment was immediately discontinued.Blood leak test strips were used and tested negative for the presence of blood.The bmt also stated that fresenius bloodlines were used for treatment and confirmed that a cracked header was observed on the dialyzer.Per bmt the patient¿s blood was not returned and stated the estimated blood loss was 250 ml.Immediately following the event, the patient was re-setup with new supplies on the same machine where the patient was able to complete treatment.The bmt confirmed that there was no patient injury, adverse events, or medical intervention required as a result of the reported event.The dialyzer was available to be returned for manufacturer evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 180NRE DIALYZER FINISHED ASSY.
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer (Section G)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key15669478
MDR Text Key306920784
Report Number0001713747-2022-00456
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100156
UDI-Public00840861100156
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K162488
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Company Representative
Reporter Occupation Biomedical Engineer
Type of Report Initial,Followup,Followup
Report Date 02/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/25/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number0500318E
Device Catalogue Number0500318E
Device Lot Number22KU07024
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Device AgeMO
Date Manufacturer Received01/31/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/31/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES
Patient Age67 YR
Patient SexFemale
Patient Weight58 KG
-
-